QurAlis to Present Data That Show its Splice-Switching ASOs Restore UNC13A Function in ALS and Frontotemporal Dementia
SV investment has resulted in the approval of 24 novel therapeutics
SV Health Investors bolsters senior biotech team - appoints Nikola Trbovic as Managing Partner and hires Jamil Beg as Partner
Hightop Health adds industry veteran to Board of Directors - Seasoned CEO and McLean Hospital Board Chair joins Hightop’s executive leadership
Merck to Acquire Caraway Therapeutics, Inc.
EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases
SV Health Investors partners with HIT Executives Dave Dyell and Marc Hirshfield to Lead Recapitalization of Innovative Consulting Group
- 12 May 2021Portfolio NewsXilio Therapeutics Presents Preclinical Tumor-Selective Activity and Tolerability Data for XTX101 at Frontiers in Cancer Immunotherapy Virtual Symposium
- 10 May 2021Portfolio NewsTherini Bio Secures $17 Million Investment to Advance Fibrin Therapeutic Candidates Towards the Clinic
- 5 May 2021Portfolio NewsXilio Therapeutics Appoints Christina Rossi to its Board of Directors
- 5 May 2021SV NewsThe Dementia Discovery Fund Appoints Luca Santarelli, M.D., a Proven Neuroscience Leader, as the New Chair of its Scientific Advisory Board
- Video4 May 2021SV NewsKate Bingham participated in the Financial Times' event: Vaccine rollout and lessons from the pandemic: watch live now
- 4 May 2021Portfolio NewsCumulus Neuroscience Announces £6 million Funding Round Led by the Dementia Discovery Fund and joined by LifeArc and UK Future Fund
- Video30 April 2021SV NewsHouman Ashrafian participated in the Female Founders panel ‘Building a diverse leadership team and board’
- 26 April 2021Portfolio NewsCatamaran Bio Announces Appointment of Scott Holmes as Chief Financial Officer
- 20 April 2021Portfolio NewsMestag Therapeutics launches with seed financing of $11 million to develop therapeutics targeting activated fibroblast populations across inflammatory disease and cancer
- 15 April 2021Portfolio NewsSutro Biopharma Earns Milestone Payment from Cytokine Derivatives Collaboration with Merck
- 15 April 2021Portfolio NewsSitryx further strengthens leadership team with the appointment of Iain Kilty, Ph.D., as Chief Scientific Officer
- 15 April 2021Portfolio NewsAlchemab raises £60M ($82M) in Series A financing to advance novel platform for identifying disease-modifying antibody therapeutics